Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

C Mueller, K McDonald, RA de Boer… - European journal of …, 2019 - Wiley Online Library
Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and
midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers for …

Role of biomarkers for the prevention, assessment, and management of heart failure: a scientific statement from the American Heart Association

SL Chow, AS Maisel, I Anand, B Bozkurt, RA De Boer… - Circulation, 2017 - Am Heart Assoc
Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure

AS Maisel, P Krishnaswamy, RM Nowak… - New England journal …, 2002 - Mass Medical Soc
Background B-type natriuretic peptide is released from the cardiac ventricles in response to
increased wall tension. Methods We conducted a prospective study of 1586 patients who …

The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study

JL Januzzi Jr, CA Camargo, S Anwaruddin… - The American journal of …, 2005 - Elsevier
The utility of aminoterminal pro-brain natriuretic peptide (NT-proBNP) testing in the
emergency department to rule out acute congestive heart failure (CHF) and the optimal …

BNP and NT-proBNP as diagnostic biomarkers for cardiac dysfunction in both clinical and forensic medicine

Z Cao, Y Jia, B Zhu - International journal of molecular sciences, 2019 - mdpi.com
Currently, brain natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) are widely
used as diagnostic biomarkers for heart failure (HF) and cardiac dysfunction in clinical …

Development and validation of real-time quantitative reverse transcriptase–polymerase chain reaction for monitoring gene expression in cardiac myocytesin vitro

J Winer, CKS Jung, I Shackel, PM Williams - Analytical biochemistry, 1999 - Elsevier
In this article we present validation of a real-time RT–PCR method to quantitate mRNA
expression levels of atrial natriuretic peptide and c-fos in anin vitromodel of cardiac …

Natriuretic peptides

LB Daniels, AS Maisel - Journal of the American college of cardiology, 2007 - jacc.org
Natriuretic peptides (NPs) are released from the heart in response to pressure and volume
overload. B-type natriuretic peptide (BNP) and N-terminal-proBNP have become important …

State of the art: using natriuretic peptide levels in clinical practice

A Maisel, C Mueller, K Adams Jr… - European journal of …, 2008 - Wiley Online Library
Natriuretic peptide (NP) levels (B‐type natriuretic peptide (BNP) and N‐terminal proBNP)
are now widely used in clinical practice and cardiovascular research throughout the world …

[HTML][HTML] Atrial and brain natriuretic peptides: Hormones secreted from the heart

Y Nakagawa, T Nishikimi, K Kuwahara - Peptides, 2019 - Elsevier
The natriuretic peptide family consists of three biologically active peptides: atrial natriuretic
peptide (ANP), brain (or B-type) natriuretic peptide (BNP), and C-type natriuretic peptide …

The natriuretic peptide system in heart failure: Diagnostic and therapeutic implications

K Kuwahara - Pharmacology & therapeutics, 2021 - Elsevier
Natriuretic peptides, which are activated in heart failure, play an important cardioprotective
role. The most notable of the cardioprotective natriuretic peptides are atrial natriuretic …